166 related articles for article (PubMed ID: 23923282)
1. Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome.
Dickson-Humphries T; Bottenberg B; Kuntz S
JAAPA; 2013 Jul; 26(7):13-8. PubMed ID: 23923282
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of dislipemia in patients with metabolic syndrome or diabetes mellitus].
Millán J;
Med Clin (Barc); 2007 May; 128(20):786-94. PubMed ID: 17568508
[No Abstract] [Full Text] [Related]
3. Persistent lipid abnormalities in diabetes; are we approaching the treatment optimally?
Hitman GA
Diabet Med; 2011 Nov; 28(11):1281. PubMed ID: 22004300
[No Abstract] [Full Text] [Related]
4. Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat?
Halcox J; Misra A
Metab Syndr Relat Disord; 2015 Feb; 13(1):1-21. PubMed ID: 25402738
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.
; ; Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F
Cardiol Rev; 2005; 13(6):322-7. PubMed ID: 16708441
[No Abstract] [Full Text] [Related]
6. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
Venkatapuram S; Shannon RP
Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924
[TBL] [Abstract][Full Text] [Related]
7. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
Srikanth S; Deedwania P
Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
[TBL] [Abstract][Full Text] [Related]
8. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
9. The insulin resistance syndrome.
Reaven GM
Curr Atheroscler Rep; 2003 Sep; 5(5):364-71. PubMed ID: 12911846
[No Abstract] [Full Text] [Related]
10. [Metabolic syndrome, resistance to insulin and diabetes. What is hidden beneath the tip of the iceberg?].
Costa B; Cabré JJ; Martín F
Aten Primaria; 2003 Apr; 31(7):436-45. PubMed ID: 12735887
[No Abstract] [Full Text] [Related]
11. Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update.
Ganne S; Arora SK; Dotsenko O; McFarlane SI; Whaley-Connell A
Curr Diab Rep; 2007 Jun; 7(3):208-17. PubMed ID: 17547838
[TBL] [Abstract][Full Text] [Related]
12. Are there specific components of the insulin resistance syndrome that predict the increased atherosclerosis seen in type 2 diabetes mellitus?
Golden SH; Chong R
Curr Diab Rep; 2004 Feb; 4(1):26-30. PubMed ID: 14764276
[TBL] [Abstract][Full Text] [Related]
13. [Consensus document on the treatment of dyslipidemia in diabetes].
Hormigo-Pozo A; Mancera-Romero J; Perez-Unanua MP; Alonso-Fernandez M; Lopez-Simarro F; Mediavilla-Bravo JJ;
Semergen; 2015 Mar; 41(2):89-98. PubMed ID: 25533449
[TBL] [Abstract][Full Text] [Related]
14. Effect of ezetimibe on cholesterol absorption and lipoprotein composition in diabetes and metabolic syndrome.
Federici M
Atheroscler Suppl; 2015 Feb; 17():17-22. PubMed ID: 25659872
[TBL] [Abstract][Full Text] [Related]
15. Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management.
Berry C; Tardif JC; Bourassa MG
J Am Coll Cardiol; 2007 Feb; 49(6):631-42. PubMed ID: 17291928
[TBL] [Abstract][Full Text] [Related]
16. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography.
Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
Diabetes Care; 2006 Apr; 29(4):901-7. PubMed ID: 16567835
[TBL] [Abstract][Full Text] [Related]
17. [Cholesterol metabolism in patients with type 2 diabetes].
Vrablík M; Tůmová E
Vnitr Lek; 2016 Mar; 62(3):189-94. PubMed ID: 27180667
[TBL] [Abstract][Full Text] [Related]
18. HIV and cardiometabolic abnormalities: new perspectives and treatment update.
Tebas P
J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S77-8. PubMed ID: 18725815
[No Abstract] [Full Text] [Related]
19. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.
Bril F; Cusi K
Diabetes Care; 2017 Mar; 40(3):419-430. PubMed ID: 28223446
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications.
Meerarani P; Badimon JJ; Zias E; Fuster V; Moreno PR
Curr Mol Med; 2006 Aug; 6(5):501-14. PubMed ID: 16918371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
